AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Which Dividend Aristocrats Etf Has Strongest Growth compares funds on growth metrics, valuation trends, and payout stability for informed choice.
28,113 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Synergy One Lending will absorb Newrez's distributed retail mortgage operations under a strategic agreement, extendin...
A famous public clash from 2013 reshaped how we think about money, risk, and accountability. This finance-forward loo...
Piper Sandler trimmed its Upstart price target to $46 after a softer Q1 EBITDA print, but kept an Overweight rating a...
A family of five confronts $85,000 in consumer debt and lays out a 3-to-4-year plan to regain financial footing, unde...
Oil prices surged after Iran closed the Strait of Hormuz again, renewing inflation concerns and pressuring Fed policy...
This week, mortgage rates tick slightly higher but remain near the 6.5% level, according to Freddie Mac. The latest d...
Ownwell secures a $50M Series B to broaden its AI-driven tax-appeals platform and roll out a nationwide packet for ho...
Millrose Properties marks its first year as an independent REIT with solid Q1 2026 earnings, expanding its builder ne...
Late-career savers confront a hard truth: retirement funding offers fewer options than college savings. Experts say c...
Investors watched Alphabet slide as news of AI talent exits raised questions about leadership and the pace of AI inve...
In a move with broad market implications, Japan's finance ministry asks a major pension fund to tilt more toward dome...